small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 19 results

Practice Area

eDiscovery & Information Governance

Winston’s eDiscovery & Information Governance Practice (eDiscovery Group) is one of the United States’ largest and most experienced. Per The Legal 500 US 2024, “[Winston has] a very strong practice from top to bottom. They have a good e-discovery consulting practice and excellent review and production capabilities and are amongst the strongest advocates you could want in a courtroom.” We have built a full-service consulting practice to support our clients and case teams in these complex areas—both domestically and globally....Read more

Industry

Government Contracts & Grants

Winston & Strawn’s Government Contracts & Grants Practice is a nationally recognized, highly regarded group of lawyers with deep experience in handling high-value, and often contentious, government contract disputes, bid protests, and claims across a broad spectrum of industries and issues. Our team also counsels clients on significant regulatory, compliance, and transactional matters—predominantly private equity and M&A deals....Read more

Practice Area

Government Program Fraud, False Claims Act & Qui Tam Litigation

Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes....Read more

Insights & News 101 results

Client Alert

|

May 1, 2025

|

3 Min Read

April 2025 Executive Order Targets Prescription Drug Price Reduction

On April 15, 2025, President Trump signed an executive order titled “Lowering Drug Prices by Once Again Putting Americans First.” The subject matter of this executive order criss-crosses considerable policy ground in the overall U.S. pharmaceutical distribution chain. The executive order sets forth the administration’s statement of objectives to reduce prescription medication costs by promoting competition and eliminating practices that lead to high drug prices. Referencing regulatory and policy actions from the first Trump administration and the Biden administration’s policy steps, including the Inflation Reduction Act of 2022 aimed at lowering prescription drug prices for Medicare beneficiaries, the executive order sets forth a broad agenda to impact Medicare prescription drug costs, including in the Medicare Part D program.[1] The order directs the Secretary of Health and Human Services (HHS) to propose and seek comment on guidance for the Medicare Drug Price Negotiation Program and collaborate with Congress to align the treatment of small molecule drugs with biological products, citing concerns about industry investment distortions and cost increases for Medicare and its beneficiaries.[2]...Read more

Client Alert

|

April 22, 2025

|

5 Min Read

Harvard University’s Tax-Exempt Status Challenged: What Nonprofits Need to Know

On March 31, 2025, the Trump administration initiated a “comprehensive review of federal contracts and grants at Harvard University and its affiliates” by the Joint Task Force to Combat Anti-Semitism (Task Force) to ensure that Harvard is “in compliance with federal regulations, including its civil rights responsibilities.” Later that same day, Alan Garber, Harvard’s President, emailed a statement to the Harvard community expressing an intent to engage with the Task Force.

Client Alert

|

March 28, 2025

|

3 Min Read

HHS Announces Major Restructuring and Workforce Reductions

On March 27, 2025, citing priorities to reduce agency budget costs and eliminate redundancy among sub-agencies, the U.S. Department of Health and Human Services (HHS) announced that it would be undergoing a significant restructuring, including cutting 20,000 jobs largely from public health agencies. 

View All Insights & News

Other Results 14 results

Site Content

Health Care Policies

Location

Dallas

Opened in 2017, Winston & Strawn’s Dallas office is located in the cultural and economic epicenter of DFW, the fourth largest metropolitan area in the U.S. and the fastest growing over the last year. Our Dallas attorneys litigate both high-stakes civil and criminal matters, including major state and federal trials and appeals nationwide, and represent clients in complex transactional matters. Under the leadership of Bryan L. Goolsby, our office—made up of nearly 100 lawyers—continues to expand, attracting some of the country’s top legal talent to meet the increased needs of the many technology, investment, and health care companies that are increasingly making Dallas their home....Read more

Site Content

The Oval Update

Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising